Search

Search Constraints

You searched for: Author/Creator Gong, Jianjian

Search Results

1. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure. Issue 1 (6th January 2015)

2. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure. Issue 1 (6th January 2015)

3. Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial. (15th April 2020)

4. Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM‐HF). (3rd June 2014)

5. Baseline characteristics of patients in the PARALLAX trial: insights into quality of life and exercise capacity in heart failure with preserved ejection fraction. (26th July 2021)

6. Dementia‐related adverse events in PARADIGM‐HF and other trials in heart failure with reduced ejection fraction. (20th November 2016)

8. Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction. (4th January 2022)

9. Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM‐HF). (12th February 2018)

10. Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy. (September 2016)